Aldeyra Therapeutics, Inc. (ALDX) Form 8-K — Nov 17, 2026
Aldeyra Therapeutics received a Nasdaq notice on November 17, 2026 because its stock closed below the $1.00 minimum bid price for 30 consecutive business days. The notice has no immediate effect on listing, and the company has until May 17, 2027 to regain compliance by closing at $1.00 or higher for 10 consecutive business days.
Key figures
- Cure period days
- 180
- Compliance deadline
- 2027-05-17
- Minimum bid price usd
- 1
- Consecutive days required to regain compliance
- 10
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.